Genome-wide association studies have linked IL-23 to IBD susceptibility via polymorphisms in the IL-23 receptor (IL-23-R) gene that enhances the activity of the IL-17/IL-23 pathway [3]. This evidence concerns the gene IL23R and inflammatory bowel disease.